Answers are grounded in this paper and cite their sources.
In early hypopharyngeal cancer, definitive radiotherapy (RT) is the preferred modality of treatment. The surgical treatment options are transoral laser microsurgery with selective neck dissection or a partial laryngopharyngectomy plus neck dissection. In locally advanced disease, concurrent chemoradiotherapy (CTRT) is the treatment of choice. Neoadjuvant chemotherapy (NACT) is also a recommended treatment option followed by radical RT/CTRT or surgery followed by adjuvant RT/CTRT, depending on the response. Some patients with locally advanced disease may require total or near total laryngectomy/total or partial pharyngectomy with appropriate neck dissection. Adding targeted therapies like nimotuzumab to cisplatin-based CTRT in locally advanced head-and-neck squamous cell carcinoma improves progression-free survival, locoregional control, and disease-free survival without negatively impacting the quality of life.
No takes yet. Share an insight, caveat, or question.
Babu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: